A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-26.03%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$158M
AUM Growth
+$158M
Cap. Flow
-$22.3M
Cap. Flow %
-14.09%
Top 10 Hldgs %
99.18%
Holding
15
New
1
Increased
–
Reduced
3
Closed
1

Top Buys

1
XCUR icon
Exicure
XCUR
$15.8M

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$22.2M
2
AVDR
Avedro, Inc Common Stock
AVDR
$14.1M
3
OCGN icon
Ocugen
OCGN
$1.18M
4
CHMA
Chiasma, Inc. Common Stock
CHMA
$530K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PSNL icon
1
Personalis
PSNL
$434M
$79.9M 50.55%
5,449,294
– –
CRSP icon
2
CRISPR Therapeutics
CRSP
$4.71B
$25.7M 16.28%
628,398
-542,870
-46% -$22.2M
XCUR icon
3
Exicure
XCUR
$35.4M
$15.8M 9.96%
+6,250,000
New +$15.8M
SIEN
4
DELISTED
Sientra, Inc.
SIEN
$15.5M 9.78%
2,390,843
– –
SLNO icon
5
Soleno Therapeutics
SLNO
$3.6B
$6.91M 4.37%
4,669,272
– –
PRTK
6
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.51M 2.85%
1,041,131
– –
VRNA
7
Verona Pharma
VRNA
$9.16B
$4.12M 2.61%
901,943
– –
SYRE icon
8
Spyre Therapeutics
SYRE
$996M
$1.85M 1.17%
240,500
– –
CHMA
9
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.83M 1.16%
370,671
-107,535
-22% -$530K
OBSV
10
DELISTED
ObsEva SA Ordinary Shares
OBSV
$731K 0.46%
87,999
– –
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
$670K 0.42%
131,036
– –
TARA icon
12
Protara Therapeutics
TARA
$120M
$525K 0.33%
2,017,872
– –
SRRA
13
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$83K 0.05%
216,667
– –
OCGN icon
14
Ocugen
OCGN
$319M
$20K 0.01%
7,111
-419,555
-98% -$1.18M
AVDR
15
DELISTED
Avedro, Inc Common Stock
AVDR
– –
-719,402
Closed -$14.1M